Beam Therapeutics Inc. vs UnitedHealth Group Incorporated — Stock Comparison

BEAM
Beam Therapeutics Inc.
$30.70
▲ 1.22%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 6/10

Q·Score Breakdown

6
Neutral
Overall
6.3
Neutral
1.1
Quality
6.2
8.7
Health
5.3
7.2
Growth
5.1
6.5
Valuation
7.3
8
Sentiment
8.1
BEAM

Clean balance sheet with low leverage (0.1× debt-to-equity).

currently unprofitable (-57% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $51.20 (+66.8%)
15 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

BEAM
UNH
Trailing P/E
27.9×
-7.0×
Forward P/E
17.8×
-57.2%
Profit Margin
2.7%
-193.1%
Gross Margin
18.8%
-8.1%
ROE
12.2%
279.5%
Revenue Growth
2.0%
Earnings Growth
0.7%
2.19
Beta
0.41
Price / Book
$3.2B
Market Cap
$334.9B
$15 – $36
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →